Abiomed, Inc. provided earnings guidance for the fiscal year 2023. For the period, the company expects revenue to be in the range $1.13 billion and $1.17 billion or 10% to 14% growth compared to fiscal year 2022.
Abiomed, Inc.
Equities
ABMD
US0036541003
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B |